🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

👉🏻 Our new publication suggests no survival benefit from adding CHT to RT in stage II NPC 👉🏻 While RT alone was effective overall, selected patients might still benefit from tailored use of CHT⁉️ 👉🏻 CONC: More data needed ✅ Melek Tugce Yilmaz MD Sepideh Mohammadipour onkder.org/abstract.php?l…

🚀 New from our clinic! "Gyroscopic Radiosurgery-Based Lattice Therapy for intracranial tumors" now published! 📝 Read our innovative article & support us by voting in the “Dedicated Cranial Radiosurgery” competition! 🔗cureus.com/articles/36963… Cureus Sepideh Mohammadipour

💥 Just published! Does Anterior Commissure Involvement Matter for Early‐Stage Glottic Cancer in the Intensity‐Modulated Radiotherapy Era? ✅ Our latest study is now available online! 👉🏻 onlinelibrary.wiley.com/doi/10.1002/he… Melek Tugce Yilmaz MD Sepideh Mohammadipour #Radiotherapy #GlotticCancer #IMRT

#YeniProfilResmi

🚨 Just out in Red Journal! We analyzed our 191-patient H&N reirradiation cohort, with a specific focus on toxicity and CBOS 📊 Real-world SBRT data 🧑‍⚕️ Lessons on patient selection & risk mitigation redjournal.org/article/S0360-… IJROBP - The Red Journal Gozde Yazici Alper Kahvecioglu MD Ecem Yigit